-
Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit
15 Dec 2025 15:41 GMT
… , but analyst Matt Phipps expects Viridian Therapeutics Inc.'s (NASDAQ …
-
SSE to go ahead with £50m battery storage site in Co Tyrone
16 Dec 2025 01:14 GMT
… for Northern Ireland (SONI) and Northern Ireland Electricity Networks (NIE).
It said delivery …
-
Analyst Says Viridian's New Thyroid Eye Drug Could Outperform Amgen's Tepezza
03 Dec 2025 21:22 GMT
William Blair initiated coverage on Viridian Therapeutics Inc. (NASDAQ:VRDN) on … mid-2026 approval.
In November, Viridian Therapeutics submitted a marketing application … veligrotug for thyroid eye disease.
Viridian’s application includes a request …
-
Viridian Metals Announces Closing of First Tranche of Financing and Short Form Vertical Amalgamation
02 Dec 2025 22:46 GMT
… (the “Amalgamation”) with Viridian Metals Corp. (the “Subsidiary … 4, 2028.
About Viridian Metals
Viridian Metals is a … the energy transition. Viridian maintains expertise in a … further information, please contact:
Viridian Metals
Tyrell Sutherland
President …
-
Viridian Metals Announces Closing of First Tranche of Financing and Short Form Vertical Amalgamation
02 Dec 2025 21:46 GMT
… 4, 2028. About Viridian Metals Viridian Metals is a leader … the energy transition. Viridian maintains expertise in a … , nickel and cobalt. Viridian’s commitment to environmental … further information, please contact: Viridian Metals
Tyrell Sutherland
President …
-
Viridian Solar offers new solutions to integrate PV systems with roof windows
20 Nov 2025 10:20 GMT
… integrated solar PV specialist Viridian Solar announced new flashing … window manufacturers, according to Viridian Solar in a statement. … backed by both companies.”
Viridian Solar recently expanded its … and building materials.
Viridian Solar was founded in …
-
RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results
17 Nov 2025 03:29 GMT
… . RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 … $300 million credit facility. Furthermore, Viridian Therapeutics, Inc. (NASDAQ:VRDN) has … firm’s bullish stance. Meanwhile, Viridian Therapeutics, Inc. (NASDAQ:VRDN) reported …
-
Viridian Therapeutics Announces Submission of BLA for Veligrotug in Thyroid Eye Disease
04 Nov 2025 20:02 GMT
… for veligrotug. If approved, Viridian has stated a goal of … and chief executive officer of Viridian Therapeutics, said in a statement … the FDA, and the entire Viridian team whose commitment has made … marks a major milestone for Viridian,” Mahoney said in a …
-
Viridian Therapeutics Submits BLA for Veligrotug in Thyroid Eye Disease Following Positive Phase 3 Results
04 Nov 2025 17:09 GMT
… and Anticipated Commercial Launch
Viridian has included a request … Mahoney, President and CEO of Viridian Therapeutics, stated:
“The … key inflection point for Viridian as we transition toward … veligrotug’s regulatory progress, Viridian is also advancing its …
-
The Viridian Bookshop ‘more than a bookshop’ in Downtown Willoughby
22 Oct 2025 16:47 GMT
… as co-owner of The Viridian Bookshop in Downtown Willoughby.
Located … and Joseph Bush opened The Viridian Bookshop on Oct. 4. Owning … and Joseph Bush opened The Viridian Bookshop on Oct. 4. Owning … and Joseph Bush opened The Viridian Bookshop on Oct. 4. …
About
© 1995-2025